Yishen Jiangu Capsules
Natural health product licensed in Canada
- Other names
- Angelica sinensis and Ginseng Capsules, Panax Ginseng, Epimedium brevicornu, and Homalomena occulta Capsules, Panax Ginseng, Notoginseng and Homalomena occulta Capsule, Renshen, Sanqi and Qiannianjian Capsules, Renshen, Yinyanghuo, Qiannianjian Capsules, Yishen Jiangu Jiaonang
- Licence holder
- 11741217 Canada Inc.
- NPN or DIN-HM
- 80132102
- Status
- Active licence
- Licence date
- 26 June 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ligusticum sinense cv. chuanxiong Source : Ligusticum sinense cv. chuanxiong - Rhizome Extract : Matériel brut sec Extraction ratio : 8.578:1 Dry plant equivalent : 120 mg | 13.99 mg | Not calculated |
| Ligustrum lucidum Source : Ligustrum lucidum - Fruit Extract : Matériel brut sec Extraction ratio : 8.567:1 Dry plant equivalent : 180 mg | 21.01 mg | Not calculated |
| Rehmannia glutinosa Extract : Matériel brut sec Extraction ratio : 8.576:1 Dry plant equivalent : 180 mg | 20.99 mg | Not calculated |
| Morinda officinalis Extract : Matériel brut sec Extraction ratio : 8.576:1 Dry plant equivalent : 180 mg | 20.99 mg | Not calculated |
| Panax ginseng Source : Panax ginseng - racine | 51 mg | Not calculated |
| Glycyrrhiza uralensis Extract : Matériel brut sec Extraction ratio : 8.571:1 Dry plant equivalent : 60 mg | 7 mg | Not calculated |
| Carthamus tinctorius Source : Carthamus tinctorius - Fleur Extract : Matériel brut sec Extraction ratio : 8.571:1 Dry plant equivalent : 60 mg | 7 mg | Not calculated |
| Reynoutria multiflora Extract : Matériel brut sec Extraction ratio : 8.576:1 Dry plant equivalent : 180 mg | 20.99 mg | Not calculated |
| Amomum villosum Source : Amomum villosum - Fruit Extract : Matériel brut sec Extraction ratio : 8.571:1 Dry plant equivalent : 60 mg | 7 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Ponceau 4R, Tartrazine, Gélatine, Amaranthe
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. Panax ginseng is used in Traditional Chinese Medicine TCM to reinforce qi, benefit the spleen and lung, relieve symptoms of thirst due to impairment of body fluids and internal heat.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132102
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.